DataMeds AI, Inc. (MEDS) Overview
- 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual -7.13; Beat / miss (m).
- 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual -0.07; Beat / miss (m).
- 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual -0.46; Beat / miss (m).
- 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual -5.40; Beat / miss (m).
Stock Price Chart
View more →Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close
Logarithmic scale. Both lines share the same starting value for the selected range.
- Last close
- $3.67
- Previous close
- $3.81
- Change
- -$0.14
- Change (%)
- -3.67%
- Close date
- 2026-09-29
- Previous close date
- 2026-09-28
- Open
- (m)
- Day high
- (m)
- Day low
- (m)
- Last session volume
- (m)
- Last session value
- (m)
- Currency
- USD
- Price basis
- split-adjusted
- Volume basis
- (m)
Performance
View more →Cumulative total returns · 2026-09-29
YTD
- MEDS
- -81.65%
- S&P 500
- (m)
1 year
- MEDS
- -92.19%
- S&P 500
- (m)
3 years
- MEDS
- (m)
- S&P 500
- (m)
5 years
- MEDS
- (m)
- S&P 500
- (m)
Earnings trends
View more →Earnings per share
USD / share · As filed
30 Jun 2026 ○ Estimate (m) ● Actual -7.13
Comparison details
| Period start | Period ending | Estimate | Actual | Beat / miss | Report date |
|---|---|---|---|---|---|
| 1 Apr 2026 | 30 Jun 2026 | (m) | -7.13 | (m) | (m) |
| 1 Jan 2026 | 31 Mar 2026 | (m) | -0.07 | (m) | (m) |
| 1 Jul 2025 | 30 Sept 2025 | (m) | -0.46 | (m) | (m) |
| 1 Apr 2025 | 30 Jun 2025 | (m) | -5.40 | (m) | (m) |
| 1 Jan 2025 | 31 Mar 2025 | (m) | -0.62 | (m) | (m) |
31 Dec 2025 ○ Estimate (m) ● Actual -1.43
Comparison details
| Period start | Period ending | Estimate | Actual | Beat / miss | Report date |
|---|---|---|---|---|---|
| 1 Jan 2025 | 31 Dec 2025 | (m) | -1.43 | (m) | (m) |
| 1 Jan 2024 | 31 Dec 2024 | (m) | -0.15 | (m) | (m) |
| 1 Jan 2023 | 31 Dec 2023 | (m) | -0.06 | (m) | (m) |
(m)
Revenue vs. Earnings
USD
30 Jun 2026 ■ Revenue 1.78M ■ Earnings -18.36M — Profit margin -1031.72%
31 Dec 2025 ■ Revenue 23.34M ■ Earnings -101.27M — Profit margin -433.95%
Analyst insights
View more →| Ratings | Buy | Hold | Sell | Other ratings | Last Close | Average Target | Upside | High Target | Low Target |
|---|---|---|---|---|---|---|---|---|---|
| (m) | (m) | (m) | (m) | (m) | $3.67 | (m) | (m) | (m) | (m) |
Recent news
View more →(m)
YouTube videos mentioning MEDS
View more →(m)
Statistics
View more →Retained observations as of 2026-11-11; financial period ending 30 Jun 2026.
- Forward P/E
- (m)
- PEG ratio · 5-year expected
- (m)
- Shares held by insiders
- (m)
- Insider transactions · change (%)
- (m)
- Shares held by institutions
- (m)
- Institutional transactions · change (%)
- (m)
- Diluted EPS · 12 month
- (m)
- EPS estimate · next quarter
- (m)
- EPS estimate · next year
- (m)
- EPS growth · current annual estimate
- (m)
- EPS growth · next annual estimate
- (m)
- EPS growth · next 5 years expected
- (m)
- EPS growth · past 3 years annualized
- (m)
- EPS growth · past 5 years annualized
- (m)
- EPS change · 12 months vs prior year
- (m)
- EPS change · latest quarter vs previous quarter
- (m)
- Latest earnings report date
- (m)
- EPS surprise · latest reported quarter
- (m)
- Net income · 12 month
- $-88.28M
- Operating margin · 12 months
- -875.75%
- Gross margin · 12 months
- -90.64%
- Profit margin
- -1100.30%
- Return on assets · 12 month
- -202.97%
- Named executive and board stock awards · latest fiscal year
- (m)
- Index membership
- (m)
- Employees
- (m)
- IPO date
- (m)
- Options available
- (m)
- Shortable
- (m)
- Analyst recommendation
- (m)
- Analyst target price
- (m)
- Price volatility · week
- (m)
- Price volatility · month
- (m)
- Average true range · 14 sessions
- (m)
- Relative strength index · 14 sessions
- (m)
- Relative volume
- (m)
- Average daily volume
- 15.94M
- Latest session volume
- (m)
- Last session value
- (m)
- 30 days ago session value
- (m)
- 1 year ago session value
- (m)
- Number of trades
- (m)
- Total return · week
- -14.15%*
- Total return · month
- 281.89%*
- Total return · quarter
- 25.26%*
- Total return · half year
- -27.33%*
- Total return · year to date
- -81.65%*
- Total return · 1 year
- -92.19%*
- Total return · 3 years
- (m)
- Total return · 5 years
- (m)
- Market cap
- (m)
- Book value per share · latest quarter
- (m)
- Price / cash · latest quarter
- (m)
- Enterprise value
- (m)
- Enterprise value / revenue
- (m)
- Enterprise value / EBITDA
- (m)
- Dividend · 12 months per share
- (m)
- Dividend ex-date
- (m)
- Next dividend ex-date
- (m)
- Next dividend amount per share
- (m)
- Dividend growth · 3 years annualized
- (m)
- Dividend growth · 5 years annualized
- (m)
- Revenue · 12 month
- $8.02M
- Revenue growth · past 3 years annualized
- (m)
- Revenue growth · past 5 years annualized
- (m)
- Revenue change · 12 months vs prior year
- (m)
- Revenue change · latest quarter vs previous quarter
- (m)
- Revenue surprise · latest reported quarter
- (m)
- Operating cash flow · 12 months
- $-13.74M
- Levered free cash flow · 12 month
- (m)
- Debt / equity · latest quarter
- (m)
- Long-term debt / equity · latest quarter
- (m)
- Return on equity · 12 month
- (m)
- Return on invested capital · 12 months
- (m)
- Previous close
- (m)
- Latest closing price
- (m)
- Latest session change (%)
- (m)
- 52-week high
- (m)
- 52-week low
- (m)
- Price vs 20-session moving average
- (m)
- Price vs 50-session moving average
- (m)
- Price vs 200-session moving average
- (m)
- Float shares
- (m)
- Short float (%)
- (m)
- Short ratio (days to cover)
- (m)
- Short interest (shares)
- (m)
Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.
Holders breakdown
View more →| Breakdown | Ownership |
|---|---|
| (m) | Shares held by all insiders |
| (m) | Shares held by institutions |
| (m) | Float held by institutions |
| (m) | Institutions holding shares |
Other holders
(m)
Insider holders
(m)
Top institutional holders
(m)
Top mutual fund holders
(m)
DataMeds AI, Inc. Overview
View more →(m)
(m)
- SEC CIK
- 2030763
- Industry (SIC)
- 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries
- Country of operation
- United States
- Business address
- 3000 BAYPORT DRIVE SUITE 950, TAMPA, Florida, 33607, United States
- Fiscal year end
- 1231
- Phone
- 1-843-302-1785
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |